Vascular Grafts Advancements Driving Innovation in Cardiovascular Treatment Solutions
Vascular grafts are critical components in the treatment of cardiovascular diseases, enabling the repair, replacement, or bypass of damaged blood vessels. These grafts are widely used in procedures such as coronary artery bypass grafting (CABG), hemodialysis access, and peripheral vascular reconstruction. Traditionally, vascular grafts have been made from synthetic materials such as expanded polytetrafluoroethylene (ePTFE) and Dacron, as well as biological sources including autologous veins and allografts. However, continuous innovation is reshaping the performance, durability, and compatibility of these devices. The global vascular grafts market size was estimated at USD 1.7 billion in 2023 and is projected to reach USD 2.8 billion by 2030, growing at a CAGR of 7.2% from 2024 to 2030. The increasing incidence of vascular diseases worldwide, including peripheral artery disease (PAD), coronary artery disease (CAD), chronic kidney disease (CKD), and aneurysms, serves a...